Headquartered in Texas, MicroTransponder Inc. has developed the Paired Vagus Nerve Stimulation (Paired VNS™) platform; the Vivistim® system is the first FDA-approved system on the platform for treatment of post-stroke upper limb impairment.
Developer of an implantable neurostimulation device designed to aid stroke recovery, and other neurological disorders. The company's device incorporates paired vagus nerve stimulation and wireless technology to deliver targeted electrical impulses, enhancing neuroplasticity, and restoring motor function in post-stroke patients, enabling healthcare practitioners to improve patient outcomes.
Developer of non-invasive neurostimulation products designed to treat global health epidemics. The company's medical device technology offers transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus to allow for alterations in autonomic function, circadian regulation, and neuro-metabolic influence, enabling healthcare providers to provide drug-free options and improve patients' health outcomes.